Dados B3 › BLAU3
BLAU3 (Blau Farmacêutica): has debt gone up?
BLAU3 (Blau Farmacêutica): at the end of 2025, net cash of R$ 16.0 million (more cash than debt); in 2024, R$ 66.1 million.
| Year | Net debt | Net debt / EBITDA | Caveat |
|---|---|---|---|
| 2025 | -R$ 16.0 million | -0.04 | — |
| 2024 | R$ 66.1 million | 0.17 | — |
| 2023 | R$ 201.2 million | 0.55 | — |
| 2022 | -R$ 331.9 million | -0.70 | — |
| 2021 | -R$ 548.3 million | -1.15 | — |
| 2020 | R$ 475.7 million | 1.17 | — |
| 2019 | R$ 119.9 million | 0.38 | — |
| 2018 | R$ 112.2 million | 0.53 | — |
| 2017 | R$ 90.7 million | 0.52 | — |
Net debt = short- and long-term borrowings minus cash and financial investments, at year end. Negative = net cash. EBITDA = operating result plus depreciation and amortization. Fact with its source; not investment advice.
Check it yourself
- Open data, no key needed for WEGE3 and with a free key for any company:
https://dadosb3.com/empresas/BLAU3/indicadores - Every annual figure comes from the DFP filed with the CVM (dados.cvm.gov.br); dividends come from B3.
- The company page shows the account each number came from: BLAU3.
Dividends · Profit · Full page · How much it returned · plain text for AI
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:13 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:13 UTC. If this does not match /saude, you are reading a cached copy.